Yoshiaki Nakamura Selected Research

Vitamin D

1/2022

Impact of serum vitamin D on the response and prognosis in breast cancer patients treated with neoadjuvant chemotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshiaki Nakamura Research Topics

Disease

59	Neoplasms (Cancer) 04/2024 - 03/2011
30	Colorectal Neoplasms (Colorectal Cancer) 03/2024 - 11/2018
24	Stomach Neoplasms (Stomach Cancer) 03/2024 - 01/2018
14	Breast Neoplasms (Breast Cancer) 04/2024 - 01/2003
10	Neoplasm Metastasis (Metastasis) 01/2023 - 02/2015
7	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 04/2024 - 01/2020
5	Disease Progression 04/2024 - 01/2003
5	Microsatellite Instability 01/2022 - 11/2018
3	Biliary Tract Neoplasms (Biliary Tract Cancer) 04/2024 - 06/2022
3	Adenocarcinoma 10/2023 - 01/2022
2	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 01/2022
2	Carcinoma (Carcinomatosis) 01/2022 - 12/2010
2	Fever (Fevers) 12/2021 - 01/2018
2	Colonic Neoplasms (Colon Cancer) 07/2021 - 01/2017
2	Neutropenia 01/2021 - 12/2019
2	Residual Neoplasm 12/2020 - 01/2019
2	Triple Negative Breast Neoplasms 01/2019 - 07/2012
1	Squamous Cell Carcinoma of Head and Neck 02/2024
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023
1	Vascular Remodeling 01/2023
1	Nervous System Diseases (Neurological Disorders) 01/2023
1	Esophageal Squamous Cell Carcinoma 10/2022
1	Lymphatic Metastasis 04/2022
1	Amyloid Plaque 01/2022

Drug/Important Bio-Agent (IBA)

20	Circulating Tumor DNAIBA 04/2024 - 11/2018
15	Biomarkers (Surrogate Marker)IBA 03/2024 - 11/2018
9	Immune Checkpoint InhibitorsIBA 02/2024 - 11/2018
9	Trastuzumab (Herceptin)FDA Link 09/2023 - 12/2010
8	NivolumabIBA 02/2024 - 01/2019
7	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 01/2020
6	Hormones (Hormone)IBA 04/2024 - 01/2016
6	human ERBB2 proteinIBA 12/2022 - 11/2014
6	pembrolizumabIBA 01/2022 - 01/2020
5	ErbB Receptors (EGF Receptor)IBA 01/2024 - 11/2018
4	Cell-Free Nucleic AcidsIBA 03/2024 - 12/2019
4	trifluridine tipiracil drug combinationIBA 11/2023 - 12/2019
4	pertuzumabIBA 07/2023 - 11/2021
4	Monoclonal AntibodiesIBA 06/2021 - 01/2019
4	Irinotecan (Camptosar)FDA LinkGeneric 06/2021 - 01/2020
3	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 04/2024 - 07/2012
3	Immunoconjugates (Immunoconjugate)IBA 03/2024 - 07/2012
3	regorafenibIBA 02/2024 - 01/2021
3	lenvatinibIBA 01/2022 - 01/2020
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 07/2021 - 02/2019
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2018 - 12/2010
2	niraparibIBA 04/2024 - 12/2022
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 04/2024 - 12/2022
2	AntibodiesIBA 03/2024 - 01/2022
2	Bispecific AntibodiesIBA 03/2024 - 07/2023
2	RNA (Ribonucleic Acid)IBA 02/2024 - 01/2022
2	RamucirumabIBA 11/2023 - 01/2020
2	Amyloid (Amyloid Fibrils)IBA 01/2023 - 01/2022
2	Docetaxel (Taxotere)FDA Link 12/2022 - 12/2021
2	trastuzumab deruxtecanIBA 06/2022 - 01/2021
2	Phosphotransferases (Kinase)IBA 01/2022 - 01/2020
2	Formaldehyde (Formol)FDA Link 01/2022 - 01/2018
2	ParaffinIBA 01/2022 - 01/2018
2	Tumor Biomarkers (Tumor Markers)IBA 10/2021 - 07/2021
2	Capecitabine (Xeloda)FDA Link 07/2021 - 02/2019
2	Bevacizumab (Avastin)FDA Link 01/2021 - 12/2019
2	Estrogen ReceptorsIBA 01/2021 - 11/2014
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2019
2	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 01/2020
2	Taxoids (Taxanes)IBA 01/2020 - 09/2017
2	AnthracyclinesIBA 09/2017 - 03/2012
2	Aromatase InhibitorsIBA 11/2016 - 03/2011
1	Epidermal Growth Factor (EGF)IBA 04/2024
1	abemaciclibIBA 04/2024
1	Indicators and Reagents (Reagents)IBA 03/2024
1	Chimeric Antigen ReceptorsIBA 03/2024
1	ClaudinsIBA 03/2024
1	zolbetuximabIBA 03/2024
1	TAS-116IBA 02/2024
1	LigandsIBA 02/2024
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2023
1	Trifluridine (Viroptic)FDA LinkGeneric 10/2023
1	tipiracilIBA 10/2023
1	tucatinibIBA 09/2023
1	eribulin FDA Link 01/2023
1	ProteomeIBA 12/2022
1	Fluorouracil (Carac)FDA LinkGeneric 10/2022
1	PlatinumIBA 10/2022
1	Notch ReceptorsIBA 10/2022
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2022
1	alectinibIBA 01/2022
1	Hematoxylin (Haematoxylon)IBA 01/2022

Therapy/Procedure

39	Therapeutics 04/2024 - 01/2003
21	Drug Therapy (Chemotherapy) 03/2024 - 12/2010
10	Precision Medicine 03/2024 - 09/2018
8	Adjuvant Chemotherapy 01/2024 - 09/2017
5	Immunotherapy 02/2024 - 01/2019
3	Genomic Medicine 11/2022 - 09/2018
3	Hepatectomy 12/2021 - 05/2002
2	Molecular Targeted Therapy 01/2022 - 01/2022
2	Neoadjuvant Therapy 01/2022 - 01/2019
2	Gastrectomy 12/2021 - 02/2019
1	Chemoradiotherapy 10/2022
1	Conformal Radiotherapy 10/2022
1	Aftercare (After-Treatment) 04/2022
1	Lymph Node Excision (Lymph Node Dissection) 04/2022